Liver transplantation for patients with hepatitis B: prevention of hepatitis B recurrence by intravenous antihepatitis B immunoglobulin and lamivudine

Transplant Proc. 2000 Nov;32(7):2245-7. doi: 10.1016/s0041-1345(00)01653-5.
No abstract available

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Cyclosporine / blood
  • Cyclosporine / therapeutic use
  • Female
  • Follow-Up Studies
  • Hepatitis B / drug therapy*
  • Hepatitis B / surgery*
  • Hepatitis B Antibodies / blood
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B e Antigens / blood
  • Humans
  • Immunization, Passive
  • Immunoglobulins / therapeutic use*
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation
  • Lamivudine / therapeutic use*
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Monitoring, Physiologic
  • Recurrence
  • Time Factors
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Immunoglobulins
  • Immunosuppressive Agents
  • Lamivudine
  • Cyclosporine
  • hepatitis B hyperimmune globulin